Friday, November 15, 2024
HomeTagsPatient Dosing

Patient Dosing

Innovent Announces First Patient Dosing in Australia in Phase I Study of IBI343 in Patients

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other...

Innovent Announces First Patient Dosing of Universal “Modular” CAR-T Cell product IBI345

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major...

Sciwind Biosciences Begins Phase 2b Clinical Trial Of Obesity Drug Candidate

Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, announced the initiation of patient...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics